Hitler's PD observed May 97 Mov Disord 1997;12:239-240 Hydrocarbon, caused by Mar 97 Ann Neur 1996;40:922-925 Incidence (survey) Jun 97 Neur 1997;48:1277-1281 " , Argentina May 97 Mov Disord 1997;12:197-205 Inderal, for dyskinesiaJul 96 Neur 1996;46:1548-1551 Iron, possible cause Jul 96 Lancet 8 Jun 1996;1614 Iron, elevated Jan 95 Ann Neur 1994;36;876-881 " Oct 95 Neur 1995;45:1138-1143 Jet fuel, hazard of Sep 97 BMJ 2 Aug 97:275 Juvenile PD Sep 96 Neur 1996;47:160-166 Kava Jun 95 J Neur N'surg Psych 1995;58:639-640 Keats, John Jan 95 Arch Neur 1994;51:1182-1183 Lamotrigine Jun 97 Neur 1997;48:1282-1286 Lazabemide Aug 96 Ann Neur 1996;40:99-107 Leukemia drugs Jul 95 Ann Neur 1995;37:810-814 Levodopa strategy Oct 95 Ann Neur 1995;38:389-395 " Dec 95 J Neur N'surg Psych 1995;59:555 " Feb 97 Neur 1996;47:Supp 3 Levodopa effects Jan 96 Neur 1995;45:1757-1760 " Jun 96 Neur 1996;46:1430-1436 " Aug 96 J Neur N'surg Psych 1996;61:634-637 " Feb 97 Mov Disord 1997;12:103-106 " Sep 97 Ann Neur 1997;42:245-248 Levodopa ethylester Apr 96 Ann Neur 1996;39:400-404 Levodopa dual-release May 97 J Clin Neuropharm 1997;20:130-139 Lewy body disease Jun 96 J Neur N'surg Psych 1996;60:531-538 " Sep 96 Neur 1996;47:462-466 " Mar 97 Neur 1997;48:376-380 Liquid Sinemet Feb 97 Neur 1996;47:1493-1495 Locus coeruleus Jun 95 Brain 1995;118:131-143 Machado-Joseph Nov 95 Ann Neur 1995;38:684-687 Macrophage Oct 96 Science News 21 Sep 96:180 Magnetic stimulation May 96 Brain 1996;119:71-77 " Sep 96 Brain 1996;119:815-822 " Oct 96 Ann Neur 1996;40:344-355 MAO inhibition, effect May 97 J Neurosci 1997;17:2267-2272 MAO-B Jun 96 Neur 1996;46:1262-1269 " Aug 96 Ann Neur 1996;40:99-107 Markers, neurochemical Oct 96 Neur 1996;47:718-726 " " May 97 Mov Disord 1997;12:167-174 " " May 97 Ann Neur 1997;41;530-539 Melatonin Jun 96 BMJ 18 May 96:1242-43 " , antioxidant Apr 97 J Neurosci 1997;17:1683-1690 Memory, Hippocampus Oct 96 Science News 7 Sep 1996:150 Memory and PD Oct 96 Science 6 Sep 96:1263-64 " Oct 96 Science 6 Sep 96:1399-02 " Jun 97 J Neur N'surg Psych 1997;62:410-413 Menstrual effects Jul 95 Neur 1995;45:1028 " Nov 95 Mov Disord 1993;8:240-241 Metaclopramide (Reglan)Jan 96 JAMA 1995;274:1780-82 Metals, exposure to Apr 97 Neur 1997;48:650-658 Methylsalsolinol Aug 96 Ann Neur 1996;40:119-122 Metronome Jun 96 Lancet 11 May 1996:1337 Migraine, DA and May 97 J Clin Neuropharm 1997;20:36-41 Mimics of PD Oct 95 Arch Neur 1995;58:294-298 " Oct 95 Brain 1995;118:951-958 " Apr 96 BMJ 16 Mar 1996:724 Mitochondria Sep 95 Science News 5 Aug 1995;84 " Feb 96 Neur 1995;45:2097-2099 " Feb 97 Mov Disord 1997;12:3-16 Mortality Apr 95 J Neur N'surg Psych 1995;58:293-299 " Apr 97 Arch Neur 1997;54:260-264 Motor Fluctuations Aug 96 J Neur N'surg Psych 1996;61:634-637 Movement, head and eye Jul 96 Ann Neur 1996;39:749-760 " , coordinated Apr 97 Brain 1997;120:91-102 " , " Jun 97 Brain 1997;120:593-604 " , " Aug 97 Brain 1997;120:963-976 " , diagnostic May 97 Arch Neur 1997;54:450-454 " , guidance Aug 97 Brain 1997;120:977-990 MPTP Dec 94 Ann Neur 1994;36:765-770 " Jan 97 J Neurosci 1996;16:7776-7782 " Feb 97 Neur 1996;47:Supp 3 Multiple System AtrophyMar 95 Ann Neur 1995;37:204-210 " Sep 95 J Neur N'surg Psych 1995;59:144-151 " Sep 97 J Clin Neuropharm 1997;20:239-244 Muscle, sound from Apr 97 Lancet 22 Feb 97;533-535 Nerve Growth Factor Apr 96 J Neurosurg 1996;84:685-689 " Nov 96 J Neurosci 1996;16:5437-5442 " Nov 96 J Neurosci 1996;16:6433-6442 " Jul 97 J Neurosurg 1997;86:511-518 " and diabetes Nov 96 Lancet 19 Oct 96:1044-45 Neuroleptics (risk) Mar 96 J Neur N'surg Psych 1996;60:213-216 Neuropeptides Sep 96 Brain 1996;119:823-830 Neurosciences Inst. Dec 95 Science 27 Oct 1995:572 Neurotrophic factors Oct 96 Ann Neur 1996;40:346 " problems Jul 97 Nat Med 1997;3:497 " (BDNF) May 97 J Neurosci 1997;17:2295=2313 Neurotrophic (GDNF) Apr 96 WSJ 21 Mar 1996: " Jan 97 N Neurosci 16:8132-8139 NMDA antagonist Nov 96 J Neurosci 1996;16:4231-39 " May 97 J Neurosci 1997;17:2921-2927 Nurr-1 May 97 Science 11 Apr 97:248-50 " , editorial May 97 Science 11 Apr 97:202 Nutrients and PD Oct 96 Neur 1996;47:644-650 Olfaction and PD Jul 97 J Neur N'surg Psych 1997;62:436-446 Ondansetron (Zofran) Oct 95 Neur 1995;45:1305-1308 " Feb 97 Neur 1996;47:1608-1609 " , for tremor Apr 97 J Neur N'Surg Psych 1997;62:282-284 On-off effect Dec 95 J Neur N'surg Psych 1995;59:555 " Aug 96 J Neur N'surg Psych 1996;61:634-637 Onset, early vs late Aug 97 Mov Disord 1997;12:277-284 Oxidative stress May 95 Neur 1995;45S3:55 " Aug 95 J Neur N'surg Psych 1995;59:90-91 " Apr 96 Ann Neur 1996;39:378-381 Pallidopyramidal Feb 96 Ann Neur 1995;38:954-956 Pallidotomy, boom in Mar 95 WSJ 22 Feb 95:1 " , benefits Jun 96 Neur 1995;45:753-761 " , " Jul 96 Lancet 25 May 96;1490 " , " Jul 96 Ann Neur 1996;39:826 " , " Apr 97 J Neur N'surg Psych 1997;62:125-132 " , " Apr 97 Lancet 15 Mar 1997:777 " , " Jun 97 Neur 1997;48:1273-1277 " , " Jul 97 Ann Neur 1997;41:834 " , cognition Sep 97 Arch Neur 1997;54:947-950 " , gamma knife Jun 96 Ann Neur 1996;39:535-538 " , history Oct 96 Ann Neur 1996;40:341-343 " , low-cost Jul 97 Brain 1997;120:729-737 " , PET scan Jul 95 Ann Neur 1995;37:776-783 " , PET scan Jun 96 Ann Neur 1996;39:450-459 " , success Oct 96 Ann Neur 1996;40:355-366 " , technique Jul 96 J Neurosurg 1996;84:194-202 " , " Jan 97 J Neurosurg 1996;85:1005-1012 " , " Aug 97 J Neurosurg 1997:87:52-59 " and DBS Jul 97 Nat Med 1997;3:671-674 " " " Jul 97 Nat Med 1997;3:602-603 Paroxetine (Paxil) Jan 95 Neur 1994;44:2406 Pathways, neural May 95 Neur 1995;45S3:S28-S34 " Nov 96 Neur 1996;1032-1036 Perception, visual May 96 Brain 1996;119:79-87 Pergolide (Permax) May 95 Neur 1995;45S3:S5 " May 95 Neur 1995;45S3:S13-S21 " May 95 Neur 1995;45S3:S22-S27 " Aug 97 Mov Disord 1997;12:402-407 Personality and PD Mar 97 Lancet 15 Feb 97:478 PET diagnosis Dec 94 Ann Neur 1994;36:759-764 " Dec 94 Ann Neur 1994;2:176-182 " Jan 96 J Neur N'surg Psych 1995;59:597-600 " Feb 96 Neur 1995;45:1995-2004 " Jun 96 Ann Neur 1996;39:450-459 " Jun 96 Neur 1996;46:1430-1436 " Jun 96 Neur 1996;46:1200-1205 " Jun 96 Ann Neur 1996;39:650-658 " Jul 96 Brain 1996;119:585-591 " Sep 96 Neur 1996;47:462-466 " Mar 97 Ann Neur 1996;40:873-884 " Mar 97 Ann Neur 1997;41:58-64 " scans, questioned May 97 Science 11 Apr 97:196-198 Porphyria and PD drugs Jul 97 J Neur N'surg Psych 1997;62:562 Pramipexole Apr 96 PDF Newsletter Spr 1996:1 " Aug 97 JAMA 9 Jul 87:125-130 " Aug 97 Neur 1997;49:162-168 Prevalence Mar 97 J Neur N'surg Psych 1997;62:10-15 Prions May 96 Science News 13 Apr 1996;228 Progenitor cells Nov 95 Eng. & Sci Sept 95:26 Progression (case hist)Feb 96 NEJM 1996;334:116-118 " Apr 96 JAMA 6 Mar 1996:716 " Nov 96 JAMA 9 Oct 1196;1171 " , in putamen Mar 97 Brain 1996;119:2097-103 Progressive Supranuc. Jun 96 J Neur N'surg Psych 1996;60:589 " Aug 96 J Neur N'surg Psych 1996;61:615-620 " Sep 96 Neur 1996;47:1-9 " Sep 96 Neur 1996;47:148-154 " Apr 97 Brain 1997;120:65-74 Propranolol Jul 96 Neur 1996;46:1548-1551 Propath program Oct 96 Arch Neur 1996;53:881-884 Proton Magnetic Res. Apr 97 J Neur N'Surg Psych 1997;62:239-242 Prozac (fluoxetine) Nov 95 Neur 1995;45:1855-1858 Psychogenic PD Sep 95 Arch Neur 1995;52:802-810 Quality of life Aug 96 J Neur N'surg Psych 1996;61:71-74 Raclopride, in PET Feb 97 Mov Disord 1997;12:33-38 Rapid-onset May 97 Neur 1997;49:1066-1069 Rating scale, clinical Sep 97 J Clin Neuropharm 1997;20:183-184 " " Sep 97 J Clin Neuropharm 1997;20:322-327 Reaction time Dec 95 J Neur N'surg Psych 1995;59:499-506 " Jan 97 Brain 1996;119:1689-1704 Reflex blink, and PD Dec 96 J Neurosci 1996;16:7308-7330 Regeneration, brain Apr 96 Lancet 16 Mar 1996:751 " Oct 96 Science News 21 Sep 1996:180 " Apr 97 Science 28 Feb 97;1318-19 " , spinal cord Oct 96 Lancet 21 Sep 1996:814 Registry (surveys) Feb 96 Neur 1995;45:1991-1995 " Feb 96 NEJM 1996;334:71-76 " Feb 96 Neur 1995;45:2143-2146 " Feb 96 Arch Neur 1996;53:66-71 Research priorities Nov 95 JAMA 25 Oct 95:1257-8 Response time, levodopaJun 96 Neur 1996;46:1055-1058 " Jun 96 Neur 1996;46:1059-1062 Restless leg syndrome Feb 96 JAMA 17 Jan 1996: " Feb 97 Neur 1996;47:1435-1441 " May 97 J Clin Neuropharm 1997;20:148-151 " Aug 97 Mov Disord 1997;12:402-407 Rigidity Feb 97 Mov Disord 1997;12:24-32 Risperidone Feb 97 Mov Disord 1997;12:119-121 " Sep 97 Mov Disord 1997;12:610-612 Salsolinol Aug 96 Ann Neur 1996;40:119-122 Selegiline , PET scan Dec 94 Ann Neur 1994;36:759-764 " , and AD May 97 NEJM 14 Apr 97:1216-22 " , benefits Feb 95 Ann Neur 1995;37:95-98 " , " May 97 Mov Disord 1997;12:175-182 " ' " Jul 97 Ann Neur 1997;41:833-834 " , DATATOP Apr 95 Arch Neur 1995;52:237-245 " , " Nov 95 Arch Neur 1995;52:564-570 " , " Mar 96 Ann Neur 1996;39:37-45 " , " Mar 96 Ann Neur 1996;39:29-36 " , dosage Aug 97 Mov Disord 1997;12:293-296 " , amphetamine Oct 95 Lancet 1995;346:64 " , protection by Jan 96 Ann Neur 1995;38:771-777 " " Aug 97 J Neurochem 1997;68:33-39 " " Aug 97 J Neurochem 1997;68:434-436 " , risks of Jan 96 BMJ 16 Dec 95:1602-7 " , " Mar 97 Ann Neur 1996;40:841-845 " , " Apr 97 Neur 1997;48:662-667 " , " Sep 97 J Clin Neuropharm 1997;20:276-278 " , in favor of Apr 96 PDF Newsletter Spr 1996:2 " , pro and con Apr 96 BMJ 16 Mar 96:702-705 " , " " " Sep 96 Ann Neur 1996;40:266-269 " , " " " Mar 97 Ann Neur 1997;41:282-283 ", special review Feb 97 Neur 1996;47:Supp 3 Serotonin syndrome Mar 97 Neur 1997;48:1070-1077 " antagonist Sep 97 J Clin Neuropharm 1997;20:300-310 Shy-Drager Mar 95 Ann Neur 1995;37:204-210 Sinemet, dissolved Sep 97 Mov Disord 1997;12:608-610 Sinemet CR Jul 95 J Neur N'surg Psych 1995;58:ad " Dec 95 Lancet 11 Nov 1995;1290 Sjogren's syndrome Feb 97 Mov Disord 1997;12:121-123 Sleep, violence in Jun 97 Lancet 19 Apr 97;1150 " , benefit Sep 97 Mov Disord 1997;12:506-508 Smell, loss of Jul 97 J Neur N'surg Psych 1997;62:436-446 Smoking and PD Sep 95 Neur 1995;45:1041 " Oct 95 Neur 1995;58:294-298 " Apr 96 Time 11 Mar 1996:60 " Apr 96 Lancet 24 Feb 1996:527 " Apr 96 Ann Neur 1996;39:378-381 " Jun 96 Neur 1996;46:1275-1284 SPECT, diagnosis by Apr 96 Neur 1996;46:278-285 " Apr 96 Neur 1996;46:231-237 " Apr 97 Brain 1997;120:103-110 " Apr 97 J Neur N'surg Psych 1997;62:133-140 Speech therapy Feb 97 Neur 1996;47:1496-1504 Stem cells, cultured Aug 97 Science News 19 Jul 97:36 " , review of May 97 Science 4 Apr 1997:66-71 Stereotactic Aug 95 J Neurosurg 1995;83:197-205 " Apr 96 Science News 30 Mar 1996:204 Stimulation, chronic Jun 96 Neur 1996;46:1150-1153 " Oct 96 Arch Neur 1996;53:898-903 Strategy, summary May 97 J Clin Neuropharm 1997;20:95-115 Strength, arm Mar 96 Ann Neur 1996;39:79-88 " Jun 97 Brain 1997;120:401-408 Striatonigral degener- Nov 96 Neur 1996;47:1032-1036 Stroke, help from Feb 97 Mov Disord 1997;12:124-126 " , adverse effect Apr 97 J Neur N'surg Psych 1997;62:288-289 Surgery, summary Mar 97 J Neur N'surg Psych 1997;62:2-8 Swallowing Mar 97 Neur 1997;48:373-375 " Aug 97 Mov Disord 1977;12:322-327 Sweats, control of Mar 95 Ann Neur 1995;37:120-122 Symmetrel (Amantadine) Jul 96 Neur 1996;46:1551-1556 Tachyphemia Aug 97 Mov Disord 1997;12:302-305 Tacrine, PD symptoms Oct 96 J Neur N'surg Psych 1996;61:324-325 Tactile acuity Aug 97 Neur 1997;49:168-177 Tardive dyskinesia Feb 97 Mov Disord 1997;12:119-121 " " , and PVP Apr 97 Lancet 15 Mar 1997:777 Thalamotomy Jun 96 J Neur N'surg Psych 1996;60:564-571 " Jan 97 Brain 1996;1717-1727 " Mar 97 Ann Neur 1997;41:108-111 Thalamus, and tremor Mar 96 Neur 1996;46:75-79 " Jun 96 Neur 1996;46:1150-1153 Therapy, tutorial Jul 96 Western J Med 1994;161:303-308 " Jul 96 Postgrad Med 1996;99:52-68 Time, judgement of Mar 96 Science News 17 Feb 1996:101 " May 96 Brain 1996;119:51-70 Tolcapone Feb 97 Neur 1997;48:81-87 Toxins, Environmental Dec 94 Ann Neur 1994;36:765-770 " Apr 95 Neur 1995;45:435-439 " Feb 96 Neur 1995'45:2112 " Jul 97 Neur 1997;48:1583-1588 Tracking, visual Jun 95 Brain 1995;118:485-493 Transcranial mag. stim May 97 J Neurosci 1997;17:3178-3184 " Aug 97 Mov Disord 1997;12:315-321 Tremor, resting PD Jun 96 Neur 1996;46:1359-1370 ", cerebellar Apr 97 J Neur N'surg Psych 1997;62:282-284 ", surgery for May 97 J Neurosurg 1997;86:642-647 Tourette Syndrome Aug 97 Mov Disord 1997:12:402-407 Ubiquitin Feb 96 Brain 1995;118:1447-49 Urinary dysfunction Jul 97 J Neur N'surg Psych 1997;62:507-511 " " Sep 97 Mov Disord 1997;12:509-513 Valproate Oct 96 Neur 1996;47:626-635 Visual perception May 96 Brain 1996;119:79-87 Vision abnormality Oct 95 Neur 1995;45:1144-1148 Visuospatial attention Jun 95 Brain 1995;118:153-166 Weight loss Feb 97 Neur 1997;48:88-91 Wine and dementia May 97 BMJ 5 Apr 97:997 Young onset Sep 96 Neur 1996;47:225-230 " " Aug 97 Mov Disord 1997;12:277-284 Zolpidem Jun 97 Lancet 26 Apr 97;1222-23 " Aug 97 Lancet 5 Jul 97;74 -- J. R. Bruman (818) 789-3694 3527 Cody Road Sherman Oaks, CA 91403-5013